Latest papers

Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.

Transdermal selegiline: the new generation of monoamine oxidase inhibitors.

Leading the way: advances in the diagnosis, treatment, and management of neuropsychiatric illnesses.

Tamoxifen protect against hydroxyl radical generation induced by phenelzine in rat striatum.

An evaluation of potential mechanism-based inactivation of human drug metabolizing cytochromes P450 by monoamine oxidase inhibitors, including isoniazid.

Quetiapine for insomnia associated with refractory depression exacerbated by phenelzine.

Treatment of depression with atypical features: a meta-analytic approach.

Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone.

Screening antidepressants in the chick separation-stress paradigm.

Inhibition of monoamine oxidase-A activity in rat brain by synthetic hydrazines: structure-activity relationship (SAR).

Chronic treatment with the monoamine oxidase inhibitor phenelzine increases hypothalamic-pituitary-adrenocortical activity in male C57BL/6 mice: relevance to atypical depression.

Validity of sudden gains in acute phase treatment of depression.

Brainstem levels of transcription factor AP-2 in rat are changed after treatment with phenelzine, but not with citalopram.

Shy-Drager syndrome: multisystem atrophy with comorbid depression.

In vivo evidence for reduced cortical glutamate-glutamine cycling in rats treated with the antidepressant/antipanic drug phenelzine.

Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients.

Effect of antidepressants on GABA(B) receptor function and subunit expression in rat hippocampus.

Modafinil augmentation of phenelzine for residual fatigue in dysthymia.

Coadministration of phenelzine and methylphenidate for treatment-resistant depression.

Antioxidant effect of phenelzine on MPP+-induced cell viability loss in differentiated PC12 cells.